NO20051187L - Depotformuleringer bestaende av aktive arylheterocykliske forbindelser i form av en suspensjon - Google Patents
Depotformuleringer bestaende av aktive arylheterocykliske forbindelser i form av en suspensjonInfo
- Publication number
- NO20051187L NO20051187L NO20051187A NO20051187A NO20051187L NO 20051187 L NO20051187 L NO 20051187L NO 20051187 A NO20051187 A NO 20051187A NO 20051187 A NO20051187 A NO 20051187A NO 20051187 L NO20051187 L NO 20051187L
- Authority
- NO
- Norway
- Prior art keywords
- depositional
- suspension
- active
- formulations consisting
- arylheterocyclic
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000000725 suspension Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 1
- MVWVFYHBGMAFLY-UHFFFAOYSA-N ziprasidone Chemical compound C1=CC=C2C(N3CCN(CC3)CCC3=CC=4CC(=O)NC=4C=C3Cl)=NSC2=C1 MVWVFYHBGMAFLY-UHFFFAOYSA-N 0.000 abstract 1
- 229960000607 ziprasidone Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42129502P | 2002-10-25 | 2002-10-25 | |
| PCT/IB2003/004535 WO2004037224A1 (fr) | 2002-10-25 | 2003-10-13 | Formulations de depot d'agents actifs arylheterocycliques sous forme de suspension |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20051187L true NO20051187L (no) | 2005-04-11 |
Family
ID=32176696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20051187A NO20051187L (no) | 2002-10-25 | 2005-03-04 | Depotformuleringer bestaende av aktive arylheterocykliske forbindelser i form av en suspensjon |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20040146562A1 (fr) |
| EP (1) | EP1562546A1 (fr) |
| JP (2) | JP2006505579A (fr) |
| KR (1) | KR20050071611A (fr) |
| CN (1) | CN1703198A (fr) |
| AR (1) | AR041826A1 (fr) |
| AU (1) | AU2003267763A1 (fr) |
| BR (1) | BR0315663A (fr) |
| CA (1) | CA2498276A1 (fr) |
| GT (1) | GT200300227A (fr) |
| MX (1) | MXPA05004299A (fr) |
| NL (1) | NL1024616C (fr) |
| NO (1) | NO20051187L (fr) |
| PA (1) | PA8586301A1 (fr) |
| PE (1) | PE20040471A1 (fr) |
| PL (1) | PL375603A1 (fr) |
| RU (1) | RU2292207C2 (fr) |
| TW (1) | TW200418477A (fr) |
| UY (1) | UY28035A1 (fr) |
| WO (1) | WO2004037224A1 (fr) |
| ZA (1) | ZA200501979B (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080113025A1 (en) * | 1998-11-02 | 2008-05-15 | Elan Pharma International Limited | Compositions comprising nanoparticulate naproxen and controlled release hydrocodone |
| US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
| SI1542668T1 (sl) * | 2002-08-20 | 2009-08-31 | Bristol Myers Squibb Co | Aripiprazol sestavljena formulacija in postopek |
| JP4865330B2 (ja) | 2002-12-13 | 2012-02-01 | デュレクト コーポレーション | 経口ドラッグデリバリーシステム |
| EP1633361A1 (fr) * | 2003-05-16 | 2006-03-15 | Pfizer Products Inc. | Traitements de l'angoisse avec la ziprasidone |
| WO2006000913A1 (fr) * | 2004-06-23 | 2006-01-05 | Pfizer Products Inc. | Procede de filtration sterile de compositions pharmaceutiques visqueuses |
| AU2005287175B2 (en) | 2004-09-17 | 2011-12-01 | Durect Corporation | Sustained local anesthetic composition containing preferably a sugar ester such as SAIB |
| EP1855651A4 (fr) * | 2005-03-03 | 2011-06-15 | Elan Pharma Int Ltd | Compositions nanoparticulaires de derives d'amide heterocyclique |
| US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
| CN100391458C (zh) * | 2006-02-07 | 2008-06-04 | 上海医药工业研究院 | 齐拉西酮或其盐包合物制备方法 |
| BRPI0711048A2 (pt) * | 2006-05-09 | 2011-08-23 | Astrazeneca Ab | formulações parenteral esterilizada e sólida estáveis, solução para administração parenteral, processos para a preparação de uma formulação e para a fabricação de um produto, método para prevenir ou tratar doenças gastrintestinais, uso de uma formulação sólida estável |
| US8337883B2 (en) | 2006-11-03 | 2012-12-25 | Durect Corporation | Transdermal delivery systems |
| AU2008347158B8 (en) | 2007-12-06 | 2013-08-22 | Durect Corporation | Oral pharmaceutical dosage forms |
| US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
| TW201521769A (zh) | 2013-03-15 | 2015-06-16 | Durect Corp | 具有流變改質劑以減少溶解變異性之組成物 |
| CN109803654B (zh) | 2017-02-23 | 2022-06-28 | 上海华汇拓医药科技有限公司 | 一种多奈哌齐半帕莫酸盐的粉针剂、包含其的组合物及它们的制备方法 |
| KR20220140711A (ko) | 2020-01-13 | 2022-10-18 | 듀렉트 코퍼레이션 | 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989002265A1 (fr) * | 1987-09-07 | 1989-03-23 | Teijin Limited | Emulsion grasse contenant un medicament, du type prepare immediatement avant l'utilisation, et procede de preparation d'une telle emulsion grasse contenant un medicament |
| GB9200247D0 (en) * | 1992-01-07 | 1992-02-26 | Erba Carlo Spa | Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation |
| JP3954115B2 (ja) * | 1992-07-28 | 2007-08-08 | アストラゼネカ・アクチエボラーグ | 注射剤および注射剤キット |
| US5594141A (en) * | 1994-11-23 | 1997-01-14 | Neurogen Corporation | Certain aminomethyl biphenyl, aminomethyl phenyl pyridine and aminomethyl phenyl pyrimidine derivatives; novel dopamine receptor subtype selective ligands |
| US6040295A (en) * | 1995-01-13 | 2000-03-21 | Genemedicine, Inc. | Formulated nucleic acid compositions and methods of administering the same for gene therapy |
| UA57734C2 (uk) * | 1996-05-07 | 2003-07-15 | Пфайзер Інк. | Комплекси включення арилгетероциклічних солей |
| DK0811386T3 (da) * | 1996-05-07 | 2005-01-03 | Pfizer | Fremgangsmåde til udvælgelse af et salt til fremstilling af et inklusionskompleks |
| PT949905E (pt) * | 1996-12-20 | 2001-12-28 | Alza Corp | Composicao de gel injectavel de efeito retardado e processo para a sua preparacao |
| EA199901013A1 (ru) * | 1997-05-16 | 2000-06-26 | Амген Инк. | Гели пролонгированного действия |
| UA72189C2 (uk) * | 1997-11-17 | 2005-02-15 | Янссен Фармацевтика Н.В. | Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот |
| RS50089B (sr) * | 1999-05-27 | 2009-01-22 | Pfizer Products Inc., | Suspenzija ziprasidona |
| MY137726A (en) * | 2000-11-22 | 2009-03-31 | Nycomed Gmbh | Freeze-dried pantoprazole preparation and pantoprazole injection |
| CA2441744C (fr) * | 2001-03-20 | 2011-07-12 | Cydex, Inc. | Preparation contenant du propofol et de la cyclodextrine d'ether sulfoalkylique |
| EP1269994A3 (fr) * | 2001-06-22 | 2003-02-12 | Pfizer Products Inc. | Compositions Pharmaceutiques comprenant un médicament et un polymère permettant d'améliorer la concentration du médicament |
| CA2458968A1 (fr) * | 2001-08-31 | 2003-03-13 | The Rockefeller University | Procede de classification de medicaments antipsychotiques |
-
2003
- 2003-10-13 WO PCT/IB2003/004535 patent/WO2004037224A1/fr active Application Filing
- 2003-10-13 KR KR1020057006963A patent/KR20050071611A/ko not_active Application Discontinuation
- 2003-10-13 CN CNA2003801011573A patent/CN1703198A/zh active Pending
- 2003-10-13 EP EP03748458A patent/EP1562546A1/fr not_active Withdrawn
- 2003-10-13 RU RU2005112202/15A patent/RU2292207C2/ru not_active IP Right Cessation
- 2003-10-13 JP JP2004546259A patent/JP2006505579A/ja active Pending
- 2003-10-13 PL PL03375603A patent/PL375603A1/xx not_active Application Discontinuation
- 2003-10-13 AU AU2003267763A patent/AU2003267763A1/en not_active Abandoned
- 2003-10-13 BR BR0315663-0A patent/BR0315663A/pt not_active IP Right Cessation
- 2003-10-13 MX MXPA05004299A patent/MXPA05004299A/es unknown
- 2003-10-13 CA CA002498276A patent/CA2498276A1/fr not_active Abandoned
- 2003-10-14 PA PA20038586301A patent/PA8586301A1/es unknown
- 2003-10-21 GT GT200300227A patent/GT200300227A/es unknown
- 2003-10-21 PE PE2003001065A patent/PE20040471A1/es not_active Application Discontinuation
- 2003-10-21 US US10/689,778 patent/US20040146562A1/en not_active Abandoned
- 2003-10-22 UY UY28035A patent/UY28035A1/es not_active Application Discontinuation
- 2003-10-23 AR ARP030103869A patent/AR041826A1/es unknown
- 2003-10-24 TW TW092129567A patent/TW200418477A/zh unknown
- 2003-10-24 NL NL1024616A patent/NL1024616C/nl not_active IP Right Cessation
-
2005
- 2005-03-04 NO NO20051187A patent/NO20051187L/no not_active Application Discontinuation
- 2005-04-08 ZA ZA200501979A patent/ZA200501979B/en unknown
-
2006
- 2006-05-23 JP JP2006142886A patent/JP2006219501A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| UY28035A1 (es) | 2004-05-31 |
| RU2005112202A (ru) | 2005-11-20 |
| JP2006219501A (ja) | 2006-08-24 |
| CA2498276A1 (fr) | 2004-05-06 |
| KR20050071611A (ko) | 2005-07-07 |
| ZA200501979B (en) | 2006-04-26 |
| MXPA05004299A (es) | 2005-08-03 |
| AU2003267763A1 (en) | 2004-05-13 |
| PL375603A1 (en) | 2005-12-12 |
| BR0315663A (pt) | 2005-08-30 |
| RU2292207C2 (ru) | 2007-01-27 |
| TW200418477A (en) | 2004-10-01 |
| WO2004037224A1 (fr) | 2004-05-06 |
| NL1024616A1 (nl) | 2004-04-27 |
| NL1024616C (nl) | 2010-04-19 |
| JP2006505579A (ja) | 2006-02-16 |
| GT200300227A (es) | 2004-06-23 |
| PA8586301A1 (es) | 2004-05-07 |
| PE20040471A1 (es) | 2004-08-14 |
| AR041826A1 (es) | 2005-06-01 |
| EP1562546A1 (fr) | 2005-08-17 |
| CN1703198A (zh) | 2005-11-30 |
| US20040146562A1 (en) | 2004-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20051187L (no) | Depotformuleringer bestaende av aktive arylheterocykliske forbindelser i form av en suspensjon | |
| HRP20080564T3 (en) | Dihydrotetrabenazines and pharmaceutical compositions containing them | |
| DK1299348T3 (da) | Forbindelser og sammensætninger til levering af aktive midler | |
| NZ542138A (en) | Heterobifunctional polymeric bioconjugates | |
| EA200701065A1 (ru) | Инъецируемые составы, содержащие нанодисперсный оланзапин | |
| WO2004098494A3 (fr) | Composés, compositions et procédés | |
| MXPA06012595A (es) | Analogos de amino-tetrazoles y metodos de uso. | |
| TW200642689A (en) | Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient | |
| DK1819353T3 (da) | Sammensætning til proteasomhæmning | |
| NO20066055L (no) | Pyridinderivater | |
| EA200700096A1 (ru) | Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии | |
| RS50510B (sr) | Formulacije koje sadrže ekteinascidin i disaharid | |
| EA200501928A1 (ru) | Пирролодигидроизохинолины как ингибиторы pde10 | |
| DK1268471T3 (da) | N-heterocykliske derivater som NOS-inhibitorer | |
| WO2004014388A8 (fr) | Derives d'heteroaryles fusionnes en 6,6 utilises comme inhibiteurs de metalloproteases matricielles | |
| NO20054787D0 (no) | Indenderivater som farmasotiske midler | |
| ATE484508T1 (de) | Furylverbindungen | |
| NO20072515L (no) | 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav | |
| NO20050666L (no) | 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer | |
| NO20061317L (no) | Imidazopyridinderivater som induserbare NO-syntaseinhibatorer | |
| CY1110034T1 (el) | Παραγωγα 1,2,4,5-τετραϋδρο-3h-βενζαζεπινων, μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν | |
| WO2004093800A3 (fr) | Derives de thyronamine et analogues et des methodes d'utilisation de ces composes | |
| AU2003250471A1 (en) | Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors | |
| CY1107028T1 (el) | Παραγωγα ινδανυλ-πιπεραζινων μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν | |
| NO20063293L (no) | Farmasoytiske forbindelser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |